Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
American Journal of Respiratory and Critical Care Medicine|October 9, 2014
Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trialYahya Shehabi, Martin Sterba, Peter Maxwell Garrett, et al.BMJ Open|May 14, 2020
Codesigning discharge communication interventions with healthcare providers, youth and parents for emergency practice settings: EDUCATE study protocolJanet A Curran, Christine Cassidy, Andrea Bishop, et al.Clinical and Translational Radiation Oncology|September 23, 2024
Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer - Multi-centre studyNgu Wah Than, D Mark Pritchard, David M Hughes, et al.The International Journal of Behavioral Nutrition and Physical Activity|November 28, 2024
Development of the 10-question household foodwork interactional assessment questionnaire (FIA-Q10)Leah E Cahill, Sharon I Kirkpatrick, Catherine L Mah, et al.Journal of the National Cancer Institute|January 2, 2017
Role of RPL39 in Metaplastic Breast CancerBhuvanesh Dave, Daniel D Gonzalez, Zhi-Bin Liu, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 12, 2018
Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in EuropeMuhammad Ahsan Javed, Georg Beyer, Nha Le, et al.Breast Cancer Research and Treatment|April 16, 2021
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancerEmre Koca, Polly Ann Niravath, Joe Ensor, et al.Breast Cancer Research and Treatment|August 8, 2019
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastasesZhe-Bin Liu, Nader E Ezzedine, Agda K Eterovic, et al.The Breast Journal|July 14, 2022
Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World ExperienceBenjamin James Hall, Ajay Ashok Bhojwani, Helen Wong, et al.Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresChad J Creighton, Xiaoxian Li, Melissa Landis, et al.Pageof 13